Table 2 NSCLC case study: Drugs, left column, and their corresponding targets, right column, related to the proposed case study
From: MiRNA therapeutics based on logic circuits of biological pathways
| Drug | Target |
|---|---|
| Osimertinib | EGFR |
| Alectinib | ALK |
| Dabrafenib | BRAF |
| Trametinib | BRAF,MEK |
| Everolimus | AKT |
| BKM120 | PI3K |
